We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 17,217

US - FDA recognizes Australia as having a comparable food safety system to the U.S.
  • Baker McKenzie
  • Australia, USA
  • April 21 2017

On April 19, 2017, the U.S. Food and Drug Administration (FDA) announced that it has signed an arrangement with the Australian Department of


The Supreme Court Addresses Legal Fee Calculations for Discovery Abuse
  • Reed Smith LLP
  • USA
  • April 21 2017

Charges of discovery abuse get thrown around frequently in product liability litigation. We have not done a scientific survey, but we guess that such


Advertising Litigation Report: Vol. 2, No. 2 - Lanham Act False Advertising
  • Kramer Levin Naftalis & Frankel LLP
  • USA
  • April 20 2017

Plaintiff Verisign, "the exclusive operator of the .com and .net internet domain names," brought a Lanham Act false advertising suit against


Advertising Litigation Report: Vol. 2, No. 2 - National Advertising Division (NAD) and National Advertising Review Board (NARB)
  • Kramer Levin Naftalis & Frankel LLP
  • USA
  • April 20 2017

A National Advertising Review Board (NARB) panel determined that the National Advertising Division (NAD) acted appropriately in deciding against


Advertising Litigation Report: Vol. 2, No. 2 - Regulatory
  • Kramer Levin Naftalis & Frankel LLP
  • USA
  • April 20 2017

A negative option is a provision in an offer or agreement to sell or provide any goods or services "under which the customer's silence or failure to


EDLA Rejects Preemption of Drug Design Defect Claim
  • Reed Smith LLP
  • USA
  • April 20 2017

Just yesterday we made the following observation: a design defect claim is often a make-weight claim. How should the design have been improved? Not


Be careful reselling a sweepstakes prize
  • Thompson Coburn LLP
  • USA
  • April 19 2017

Shortly after posting my article on sweepstakes winners who didn’t want the prize they had won, I noticed several articles about a sweepstakes winner


FDA Approval of 23andMe Genomic Test Shows the Way for Direct-to-Consumer Diagnostics
  • Knobbe Martens Olson & Bear LLP
  • USA
  • April 19 2017

On April 6, 2017 the FDA Center for Devices and Radiological Health formally approved 23andMe’s Personal Genome Services Test as a Class II Medical


WDNY Holds that Tysabri Warnings are Adequate as Matter of Law and that Product Liability Claims are Preempted
  • Reed Smith LLP
  • USA
  • April 19 2017

However a drugdevice product liability is styled, it will almost always be focused on a claim of failure to warn. Why do plaintiffs insist on


Update on Contamination of Heater-Cooler Devices
  • Stark & Stark
  • USA
  • April 18 2017

The Food and Drug Administration (FDA) recently issued a Medical Device Safety Communication update to provide new information about Mycobacterium